MESO logo

MESO
Mesoblast limited.

5,260
Mkt Cap
$1.91B
Volume
173,195.00
52W High
$21.50
52W Low
$9.61
PE Ratio
-20.08
MESO Fundamentals
Price
$14.81
Prev Close
$15.80
Open
$15.00
50D MA
$16.15
Beta
1.47
Avg. Volume
329,473.54
EPS (Annual)
-$0.8443
P/B
3.32
Rev/Employee
$211,960.04
$1,281.89
Loading...
Loading...
News
all
press releases
Mesoblast (NASDAQ:MESO) Shares Down 5.5% - Here's Why
Mesoblast (NASDAQ:MESO) Shares Down 5.5% - Here's Why...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Pass Below 50 Day Moving Average - Time to Sell?
Mesoblast (NASDAQ:MESO) Share Price Passes Below 50 Day Moving Average - Here's Why...
MarketBeat·4d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Trading Up 9.3% - What's Next?
Mesoblast (NASDAQ:MESO) Shares Up 9.3% - Still a Buy...
MarketBeat·11d ago
News Placeholder
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. PR...
PR Newswire·18d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Cross Below 50-Day Moving Average - Time to Sell?
Mesoblast (NASDAQ:MESO) Stock Price Crosses Below Fifty Day Moving Average - Should You Sell...
MarketBeat·24d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's Why
Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's Why...
MarketBeat·1mo ago
News Placeholder
Mesoblast (NASDAQ:MESO) Stock Price Down 8.5% - Here's What Happened
Mesoblast (NASDAQ:MESO) Shares Down 8.5% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What Happened
Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Mesoblast H1 Earnings Call Highlights
Mesoblast (NASDAQ:MESO) executives highlighted strong early commercial momentum for its cell therapy Ryoncil and outlined multiple regulatory and clinical milestones ahead during the company's...
MarketBeat·1mo ago
News Placeholder
What's Next: Mesoblast's Earnings Preview
read more...
Benzinga·1mo ago
<
1
2
...
>

Latest MESO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.